Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Lešnjaković, Lucija ; Ganoci, Lana ; Bilić, Ivan ; Šimičević, Livija ; Mucalo, Iva ; Pleština, Stjepko ; Božina, Nada
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? // Pharmacogenomics, 24 (2023), 0135, 14. doi: 10.2217/pgs-2022-0135
Ganoci, L. ; Lešnjaković, L. ; Šimičević, L. ; Palić, J. ; Mucalo, I. ; Božina, N.
DPYD haplotype structure for variants *2A, *13, c.2846A>T, c.1236G>A/HapB3, c.496A>G (rs2297595), *6 (rs1801160) and *9A (rs1801265) in the Croatian population. 2023. str. /-/
Dominko, Kristina ; Rastija, Ana ; Smiljanić, Kosara ; Mladenović, Aleksandra ; Lešnjaković, Lucija ; Kanazir, Selma ; Milanović, Desanka ; Hećimović, Silva
Amyloid-ß plaque formation and BACE1 accumulation in the brains of a 5xFAD Alzheimer's disease mouse model is associated with altered distribution and not proteolysis of BACE1 substrates Sez6 and Sez6L // Mechanisms of ageing and development, 207 (2022), 111726, 11. doi: 10.1016/j.mad.2022.111726
Božina, Nada ; Bilić, Ivan ; Ganoci, Lana ; Šimičević, Livija ; Pleština, Stjepko ; Lešnjaković, Lucija ; Trkulja, Vladimir
DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine-based protocols // British journal of clinical pharmacology, 88 (2022), 5; 2190-2202. doi: 10.1111/bcp.15144
Ganoci, L. ; Bilić, I. ; Trkulja, V. ; Lešnjaković, L. ; Šimićević, L. ; Mucalo, I. ; pleština, S. ; Božina, N.
DPYD polymorphism c.496A>G and risk of severe adverse drug reactions in cancer patients treated with fluoropyrimidine-based protocols. 2021. str. /-/
